Fig. 4From: Interaction between baseline HBV loads and the prognosis of patients with HCC receiving anti-PD-1 in combination with antiangiogenic therapy undergoing concurrent TAF prophylaxisAmong the 70 patients, 2 had HBV reactivation. a Characteristics of the 2 patients with HBV reactivation; b Kinetics of HBV DNA in the 2 patients with HBV reactivationBack to article page